IP Library Granted Patent US 8,741,357
Granted Patent B2
US 8,741,357 · App. 11/795,330 · Granted Jun 3, 2014

Cosmetic or dermopharmaceutical composition comprising an euglena extract

Inventors: Karl Lintner (Rambouillet, FR); Claire Mas Chamberlin (Chevreuse, FR); Louis François Lamy (Orlienas, FR); Philippe Mondon (Paris, FR)
Assignee: Sederma SAS
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,357
App. No.
11/795,330
Granted
Jun 3, 2014
Kind
B2
Abstract

The invention provides a cosmetic or dermopharmaceutic composition containing an Euglena extract, its use to activate the cellular metabolism and in particular to protect and/or improve the state of the skin and to reduce the signs of ageing in particular and/or cutaneous fatigue.

Claims (14)

1. A method of treating and/or reducing loss of skin elasticity or loss of skin firmness comprising topically applying to the skin of a subject in need thereof a cosmetic or dermopharmaceutical composition containing an amount of an Euglena gracilis extract sufficient to reconstitute intracellular ATP in the skin cells, generate IP 3 in the skin cells, or trigger release of intracellular calcium in the skin cells to which it is applied, and a dermatologically acceptable carrier, whereby said Euglena gracilis extract is prepared by culturing Euglena gracilis in a culture medium, lysing the Euglena gracilis , separating the solids from the liquid phase, and collecting said liquid phase whereby said liquid phase is the extract of Euglena gracilis , and wherein the Euglena gracilis extract includes a total phospholipid content of between about 0.002% (w/w) and about 5% (w/w).

2. The method according to claim 1 , wherein said Euglena gracilis extract is present at a concentration from 0.01% (w/w) to 100% (w/w) by weight of the composition.

3. The method according to claim 2 , wherein the Euglena gracilis extract is present at a concentration from 0.1% (w/w) to 30% (w/w) by weight of the composition.

4. The method according to claim 3 , wherein the Euglena gracilis extract is present at a concentration from 0.5% (w/w) to 5% (w/w) by weight of the composition.

5. The method according to claim 1 , wherein the cosmetic or dermopharmaceutical composition further comprises at least one skin care active.

6. The method according to claim 5 , wherein the at least one skin care active is selected from the group consisting of peptidic compounds, vitamin A (retinol), vitamin E (tocopherol), alpha hydroxy acids (AHA), isoflavones, and active oxygen-generation inhibitors.

7. The method according to claim 1 , wherein the cosmetic or dermopharmaceutical composition further comprises a skin anti-aging agent, anti-wrinkle agent, anti-atrophy agent, anti-oxidant or radical scavenger.

8. The method according to claim 1 , wherein the Euglena extract is in the form of a solution, dispersion, emulsion, paste, powder, macrocapsule, microcapsule, nanocapsule, macrosphere, microsphere, nanosphere, liposome, oleosome, chylomicron, macroparticle, microparticle, nanoparticle, macrosponge, microsponge or nanosponge; or wherein the extract is adsorbed on organic polymer powders, talcs, bentonites or other inorganic supports.

9. The method according to claim 1 , wherein the composition is in the form of a cream, lotion, ointment, milk, gel, emulsion, dispersion, solution, suspension, cleanser, foundation, anhydrous preparation, stick, lipstick, body or bath oil, shower or bath gel, cream or lotion for care of the skin, sun-screen lotion, artificial tanning lotion, shaving cream or foam, aftershave lotion, mascara, nail varnish, serum, adhesive or absorbent material, transdermal patch, powder, emollient lotion, emollient milk, emollient cream, spray, bath or body oil, make-up, foundation tint base, pomade, colloid, compact or solid suspension, pencil, or sprayable formulation.

10. The method of claim 1 wherein said cosmetic or dermopharmaceutical composition is applied to the face of the subject.

11. The method of claim 10 wherein said cosmetic or dermopharmaceutical composition is applied to the lips of the subject.

12. The method of claim 10 wherein said cosmetic or dermopharmaceutical composition is applied to the eye area of the subject.

13. The method of claim 1 wherein said cosmetic or dermopharmaceutical composition is applied to stretch marks on the skin of the subject.

14. The method of claim 1 wherein said applying comprises continuously, topically applying to the subject via skin/textile contact.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME SEDERMA SAS PREVIOUSLY RECORDED ON REEL 022933 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE NAME SHOULD BE SEDERMA. Recorded Mar 22, 2019
From: SEDERMA SAS
To: SEDERMA
Reel/Frame 048674/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2009
From: LINTNER, KARL; CHAMBERLIN, CLAIRE MAS; LAMY, LOUIS FRANCOIS; MONDON, PHILIPPE
To: SEDERMA SAS
Reel/Frame 022933/0001 →
Priority Claims (1)
FR 05 00431 · Jan 14, 2005 · national
Continuity (1)
Related Publication 20090017147A1 · Jan 15, 2009